Flywheel Announces Hooman Hakami to Interim CEO Appointment
Flywheel Announces Hooman Hakami to Interim CEO Appointment
MINNEAPOLIS, May 24, 2024 /PRNewswire/ -- Flywheel Exchange, Inc, the leading medical imaging data management and AI enablement company, today announced the appointment of Hooman Hakami as Interim CEO, effective immediately. Hooman will serve as Interim CEO until a long-term CEO is hired and successfully onboarded. Flywheel is currently conducting an extensive search for a long-term CEO to drive its next phase of growth in developing the leading end-to-end platform to manage and operationalize medical imaging data securely and efficiently at scale.
明尼阿波利斯，2024年5月24日 /PRNewswire/ — 領先的醫學成像數據管理和人工智能支持公司Flywheel Exchange, Inc今天宣佈任命胡曼·哈卡米爲臨時首席執行官，立即生效。在聘用長期首席執行官併成功入職之前，胡曼將擔任臨時首席執行官。Flywheel目前正在廣泛尋找長期首席執行官，以推動其下一階段的增長，開發領先的端到端平台，以安全、高效地大規模管理和運營醫學成像數據。
Hooman is a seasoned executive with 30 years of business leadership experience in healthcare. Prior to Flywheel, Hooman co-founded Forte Health Advisors, a specialized healthcare advisory firm enabling innovators to transform healthcare. Previously, Hooman served in executive business roles at GE Healthcare and Medtronic, including serving on Medtronic's Executive Committee. Hooman has held multiple leadership roles throughout his career, including as President of GE's X-Ray product portfolio and Executive Vice President of Medtronic's Diabetes Group.
胡曼是一位經驗豐富的高管，在醫療保健領域擁有30年的商業領導經驗。在加入Flywheel之前，胡曼與他人共同創立了Forte Health Advisors，這是一家專業的醫療保健諮詢公司，幫助創新者實現醫療保健轉型。此前，胡曼曾在通用電氣醫療和美敦力擔任行政業務職務，包括在美敦力執行委員會任職。胡曼在其職業生涯中擔任過多個領導職務，包括擔任通用電氣X射線產品組合總裁和美敦力糖尿病集團執行副總裁。
"Flywheel's Board is delighted to appoint Hooman as Interim CEO," said Marijn Dekkers, Flywheel Board Member and Chairman of Novalis LifeSciences. "Hooman is an experienced healthcare executive and an ideal leader to steward Flywheel through this period of leadership transition. Hooman's domain expertise, strong business acumen, and steady leadership will help Flywheel scale and strengthen its leading position as the pre-eminent medical imaging data management and AI enablement company."
飛輪董事會成員兼諾瓦利斯生命科學董事長瑪麗恩·德克斯表示：“飛輪董事會很高興任命胡曼爲臨時首席執行官。”“胡曼是一位經驗豐富的醫療保健高管，也是領導Flywheel度過這段領導層過渡時期的理想領導者。Hooman的領域專業知識、強大的商業頭腦和穩定的領導地位將幫助Flywheel擴大和鞏固其作爲卓越的醫學成像數據管理和人工智能支持公司的領先地位。”
"I am very grateful for the Board's confidence and support," said Hooman. "I have been nothing but impressed with the depth and expertise of the Flywheel team and the clear value its solutions create for customers, who span the entire Healthcare value chain. I have no doubt that Flywheel can continue to scale and be at the forefront of data management and AI across the global Healthcare landscape. I look forward to working with the team and the Board, to support the Company and its customers during this period of transition."
胡曼說：“我非常感謝董事會的信心和支持。”“Flywheel團隊的深度和專業知識以及其解決方案爲涵蓋整個醫療保健價值鏈的客戶創造的明顯價值，給我留下了深刻的印象。我毫不懷疑，Flywheel可以繼續擴大規模，在全球醫療保健領域處於數據管理和人工智能的最前沿。我期待與團隊和董事會合作，在這段過渡時期爲公司及其客戶提供支持。”
About Flywheel
關於飛輪
Flywheel is the pioneering medical imaging AI platform powering healthcare innovation through streamlined data management, curation, and analysis. Flywheel helps organizations turn complex imaging data into analysis-ready datasets for accelerated research and AI development. Flywheel offers comprehensive solutions for pharma companies, providers, payers, system integrators, AI developers and academic medical centers to get optimum value out of their data assets. Flywheel is an Invenshure-founded company headquartered in Minneapolis, Minnesota. For more information on our mission and products, visit or follow us on LinkedIn and X.
Flywheel是開創性的醫學成像人工智能平台，通過簡化的數據管理、管理和分析推動醫療創新。Flywheel 幫助組織將複雜的成像數據轉化爲可用於分析的數據集，以加速研究和 AI 開發。Flywheel爲製藥公司、提供商、付款人、系統集成商、人工智能開發人員和學術醫療中心提供全面的解決方案，以從其數據資產中獲得最佳價值。Flywheel是一家由Invenshure創立的公司，總部位於明尼蘇達州明尼阿波有關我們的使命和產品的更多信息，請在 LinkedIn 和 X 上訪問或關注我們。
SOURCE Flywheel
來源 Flywhe
譯文內容由第三人軟體翻譯。